Get started
Author

Christopher K. Ledbetter

Observed name: Christopher Ledbetter
OpenAlex ID: A5069546645
Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer
2017 · Suriyan Ponnusamy, Christopher C. Coss, et al. · Cancer Research · 95
PDF
National trends in hospitalization from indwelling urinary catheter complications, 2001–2010
2013 · Janet Colli, Bayo Tojuola, et al. · International Urology and Nephrology · 26
1055 Septicemia in U.s. Hospitals in 2010
2013 · Evan Dunn, Janet Colli, et al. · The Journal of Urology · 14
A Rare Inherited 15q11.2-q13.1 Interstitial Duplication with Maternal Somatic Mosaicism, Renal Carcinoma, and Autism
2016 · Nora Urraca, Brian Potter, et al. · Frontiers in Genetics · 7
PDF
712 Risk of Development of Proteinuria With Androgen Deprivation Therapy for Prostate Cancer
2011 · Reza Mehrazin, Michael Aleman, et al. · The Journal of Urology · 1
Mp04-10 Oncologic Outcomes of Whole Gland Cryoablation for Primary Treatment of Prostate Cancer: a 10 Year Single Institution Experience
2025 · William Fry, Shimron Brown, et al. · The Journal of Urology
Data from Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer
2023 · Suriyan Ponnusamy, Christopher C. Coss, et al.
Supporting Figures S5-S8 from Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer
2023 · Suriyan Ponnusamy, Christopher C. Coss, et al.
Supporting figure legends and methods from Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer
2023 · Suriyan Ponnusamy, Christopher C. Coss, et al.
Supporting Figures S1-S4 from Novel Selective Agents for the Degradation of Androgen Receptor Variants to Treat Castration-Resistant Prostate Cancer
2023 · Suriyan Ponnusamy, Christopher C. Coss, et al.
Pd60-07 Objective Risk Score Reliably Predicts Major Morbidity and Mortality After Radical Prostatectomy
2022 · Kristen Maatman, Christopher Ledbetter, et al. · The Journal of Urology
Pd16-01 Objective Risk Score Reliably Predicts Mortality After Radical Nephrectomy
2021 · Kristen Marley, Bradley Houston, et al. · The Journal of Urology
Mp23-17 Socioeconomic Factors Predict Delay in Prostate Cancer Treatment Decision and Initiation
2021 · Patrick Probst, Hunter Kraus, et al. · The Journal of Urology
Mp18-15 Increased Stone Burden, Anatomy Complexity, Cystine Stone Composition and Ir Access Predict Lower Stone Free Rates
2021 · Patrick Probst, Hunter Kraus, et al. · The Journal of Urology
Acupuncture for Analgesia During Transurethral Resection of Bladder Tumor
2019 · Aaron S. Bloch, Paul J. Bloch, et al. · Journal of Endourology Case Reports
Lb-s&t-06 Novel Dual-binding Selective Degraders of Full Length and Splice Variant Androgen Receptors for the Treatment of Castration-resistant Prostate Cancer
2016 · Suriyan Ponnusamy, Christopher Coss, et al. · The Journal of Urology
PDF
1937 a Critical Analysis of Inpatient Use of Serum Psa Testing
2013 · Evan Dunn, Christopher Henry, et al. · The Journal of Urology
207 a Survey of Current Practices in the Management of Bladder Trauma
2011 · Jeremy Norwood, Christopher Ledbetter, et al. · The Journal of Urology
1938 Risk of Diabetes Mellitus and Hypertension After Extracorporeal Shock Wave (eswl) Therapy for Urinary Stone Disease
2011 · Reza Mehrazin, Michael Aleman, et al. · The Journal of Urology
781: Nephron Sparing Surgery in Cases of Synchronous Bilateral Wilms’ Tumors and Wilms’ Occurring in Solitary Kidneys: Long-Term Oncologic Outcomes
2006 · Dana W. Giel, Mark A. Williams, et al. · The Journal of Urology
Works count: 20
Citation count: 143
H-index: 4
I10-index: 3
Year
Topic
Type